Literature DB >> 25312040

Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia.

Mathieu Bastard1, Elisabeth Sanchez-Padilla1, Cathy Hewison2, Armen Hayrapetyan3, Shazina Khurkhumal4, Francis Varaine2, Maryline Bonnet1.   

Abstract

BACKGROUND: The success of the current treatment regimen for multidrug-resistant (MDR) tuberculosis is poor partly owing to a high default rate. Many studies have explored predictors of poor outcomes, but very few have assessed the effects of treatment interruptions on treatment outcomes for MDR tuberculosis.
METHODS: We conducted a retrospective analysis among patients with MDR tuberculosis enrolled in 2 MDR tuberculosis programs using regimens recommended by the World Health Organization under directly observed therapy. Treatment outcomes were defined as successful if the patient was cured or completed treatment and unsuccessful if the patient died or defaulted from treatment or if treatment failed. The effect of patterns of interruptions on treatment outcomes was assessed through multivariate logistic regression.
RESULTS: A total of 393 patients with MDR tuberculosis were included in the study; 171 (43.5%) had a successful outcome, and 222 (56.5%) an unsuccessful outcome: 39 (9.9%) died, 56 (14.3%) had failed treatment, and 127 (32.3%) defaulted from treatment. In multivariate analysis, long interruptions (≥3 days) (adjusted odds ratio, 3.87; 95% confidence interval, 1.66-8.98) and short gaps (<10 days) between interruptions (3.94; 1.76-8.81) were independently associated with an unsuccessful treatment outcome. DISCUSSION: This study shows that in a directly observed therapy-based MDR tuberculosis program, treatment interruptions at short intervals of ≥3 days directly affect treatment outcome.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  duration; gaps; multidrug-resistant; outcomes; treatment interruptions; tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 25312040     DOI: 10.1093/infdis/jiu551

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.

Authors:  Mathieu Bastard; Elisabeth Sanchez-Padilla; Philipp du Cros; Atadjan Karimovich Khamraev; Nargiza Parpieva; Mirzagaleg Tillyashaykov; Armen Hayrapetyan; Kamene Kimenye; Shazina Khurkhumal; Themba Dlamini; Santiago Fadul Perez; Alex Telnov; Cathy Hewison; Francis Varaine; Maryline Bonnet
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

2.  Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey.

Authors:  Bella Hwang; Amir Shroufi; Tinne Gils; Sarah Jane Steele; Anna Grimsrud; Andrew Boulle; Anele Yawa; Sasha Stevenson; Lauren Jankelowitz; Marije Versteeg-Mojanaga; Indira Govender; John Stephens; Julia Hill; Kristal Duncan; Gilles van Cutsem
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

3.  Drug Non-Adherence And Reasons Among Multidrug-Resistant Tuberculosis Patients In Guizhou, China: A Cross-Sectional Study.

Authors:  Yun Wang; Huijuan Chen; Zhongfeng Huang; Edward B McNeil; Xiaolong Lu; Virasakdi Chongsuvivatwong
Journal:  Patient Prefer Adherence       Date:  2019-09-30       Impact factor: 2.711

4.  IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial.

Authors:  Helen R Stagg; Ibrahim Abubakar; Colin Nj Campbell; Andrew Copas; Marcia Darvell; Robert Horne; Karina Kielmann; Heinke Kunst; Mike Mandelbaum; Elisha Pickett; Alistair Story; Nicole Vidal; Fatima B Wurie; Marc Lipman
Journal:  BMJ Open       Date:  2019-12-17       Impact factor: 2.692

Review 5.  All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era.

Authors:  Helen R Stagg; Mary Flook; Antal Martinecz; Karina Kielmann; Pia Abel Zur Wiesch; Aaron S Karat; Marc C I Lipman; Derek J Sloan; Elizabeth F Walker; Katherine L Fielding
Journal:  ERJ Open Res       Date:  2020-11-02

6.  Unfavorable Treatment Outcome and Its Predictors Among Patients with Multidrug-Resistance Tuberculosis in Southern Ethiopia in 2014 to 2019: A Multi-Center Retrospective Follow-Up Study.

Authors:  Lemlem Bogale; Tewodros Tsegaye; Mohamed Abdulkadir; Temesgen Yihunie Akalu
Journal:  Infect Drug Resist       Date:  2021-04-08       Impact factor: 4.003

Review 7.  Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis.

Authors:  Jia Yin; Jinqiu Yuan; Yanhong Hu; Xiaolin Wei
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

8.  Temporal Factors and Missed Doses of Tuberculosis Treatment. A Causal Associations Approach to Analyses of Digital Adherence Data.

Authors:  Helen R Stagg; James J Lewis; Xiaoqiu Liu; Shitong Huan; Shiwen Jiang; Daniel P Chin; Katherine L Fielding
Journal:  Ann Am Thorac Soc       Date:  2020-04

9.  Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia.

Authors:  Habteyes H Tola; Kourosh Holakouie-Naieni; Mohammad A Mansournia; Mehdi Yaseri; Ephrem Tesfaye; Zemedu Mahamed; Million Molla Sisay
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

10.  Treatment interruption and associated factors among patients registered on drug-resistant tuberculosis treatment in Amhara regional state, Ethiopia: 2010-2017.

Authors:  Mehari Woldemariam Merid; Atalay Goshu Muluneh; Melaku Kindie Yenit; Getahun Molla Kassa
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.